[Characteristic analysis of patients with type 2 diabetes mellitus combined with advanced stage chronic liver disease: a community population-based cross-sectional study in Heping District, Shenyang City (CHESS-LN 2101)].

医学 内科学 慢性肝病 脂肪肝 腰围 糖尿病 人口 胃肠病学 肝病 横断面研究 体质指数 2型糖尿病 非酒精性脂肪肝 肝硬化 疾病 病理 环境卫生 内分泌学
作者
C Lyu,Wenjin Fu,Ye Gu,L S Wang,X M Wang,X Liu,J M Qian,Z Tao,Y Chen,C Liu,R L He,X Guan,Y Wang,Y Wang,X L Qi
出处
期刊:PubMed 卷期号:30 (11): 1194-1200
标识
DOI:10.3760/cma.j.cn501113-20210810-00390
摘要

Objective: To investigate the prevalence and independent risk factors of non-alcoholic fatty liver disease (NAFLD) and advanced chronic liver disease among the type 2 diabetes mellitus (T2DM) population in the Shenyang community, so as to provide evidence for the prevention and control of T2DM combined with NAFLD. Methods: This cross-sectional study was conducted in July 2021. 644 T2DM cases from 13 communities in Heping District, Shenyang City were selected. All the surveyed subjects underwent physical examination (measurements of height, body mass index, neck circumference, waist circumference, abdominal circumference, hip circumference, and blood pressure), infection screening (excluding hepatitis B and C, AIDS, and syphilis), random fingertip blood glucose, controlled attenuation parameter (CAP), and liver stiffness measurement (LSM). The study subjects were divided into the non-advanced chronic liver disease group and the advanced chronic liver disease group according to whether the LSM value was greater than 10 kPa. Cirrhotic portal hypertension development was indicated in patients with LSM ≥ 15 kPa. The comparison of multiple mean values among the sample groups was performed by analysis of variance when the normal distribution was met. Results: In the T2DM community population, there were 401 cases (62.27%) combined with NAFLD, 63 cases (9.78%) combined with advanced chronic liver disease, and 14 cases (2.17%) combined with portal hypertension. There were 581 cases in the non-advanced chronic liver disease group and 63 cases (9.78%) in the advanced chronic liver disease group (LSM ≥10 kPa), including 49 cases (7.61%) with 10 kPa≤LSM<15 kPa, 11 cases (1.71%) with 15 kPa ≤LSM<25 kPa, and 3 cases (0.47%) with LSM ≥ 25 kPa. Age, body mass, body mass index, neck circumference, waist circumference, hip circumference, waist-to-height ratio, systolic blood pressure, and CAP were all statistically different between the non-advanced chronic liver disease group and the advanced chronic liver disease group (F=-1.983,-2.598,-4.091,-2.062,-3.909, -4.581,-4.295,-2.474, and -5.191, respectively; P<0.05). There was a statistically significant difference in terms of whether or not there was combined cerebrovascular disease (2=4.632, P=0.031); however, there were no statistically significant differences in terms of lifestyle, diabetes complications, and other complications (P>0.05). Conclusion: Patients with T2DM have a higher prevalence of NAFLD (62.27%) than those with advanced chronic liver disease (9.78%). 2.17% of T2DM cases in the community may not have had early diagnosis and early intervention, and they might have been combined with cirrhotic portal hypertension. So, the management of these patients should be strengthened.目的: 探讨沈阳社区2型糖尿病(T2DM)人群中非酒精性脂肪性肝病(NAFLD)、进展期慢性肝病的患病率和独立危险因素,为社区T2DM合并NAFLD的预防及控制提供依据。 方法: 于2021年7月在沈阳市和平区13个社区,入选T2DM患者644例进行横断面研究,对所有调查对象进行体格检查(测量身高、体质量、颈围、腰围、腹围、臀围、血压)、传染筛查(排除乙型肝炎、丙型肝炎、艾滋病、梅毒)、随机指尖血糖以及受控衰减参数(CAP)、肝脏硬度值(LSM)检查。研究对象根据LSM值是否大于10 kPa分为无进展期慢性肝病组和进展期慢性肝病组,其中LSM≥15 kPa提示患者发展为肝硬化门静脉高压。样本中组间多个均数的比较,符合正态分布时采用方差分析。 结果: 在社区T2DM人群中,合并NAFLD患者401例(62.27%),合并进展期慢性肝病患者63例(9.78%),合并门静脉高压者14例(2.17%)。无进展期慢性肝病组581例;进展期慢性肝病(LSM≥10 kPa)组[63例(9.78%)],其中:10 kPa≤LSM<15 kPa 49例(7.61%),15 kPa≤LSM<25 kPa 11例(1.71%),LSM≥25 kPa者3例(0.47%)。无进展期慢性肝病组和进展期慢性肝病组在年龄、体质量、体质量指数、颈围、腰围、臀围、腰高比、收缩压、CAP比较,差异均有统计学意义(F值分别为-1.983、-2.598、-4.091、-2.062、-3.909、-4.581、-4.295、-2.474、-5.191;P值均<0.05);两组在是否合并脑血管疾病上差异有统计学意义(χ2=4.632,P=0.031);而在生活习惯、糖尿病合并症及其他并发症方面比较,P值均>0.05,差异均无统计学意义。 结论: 在T2DM中NAFLD的患病率较高,为62.27%,进展期慢性肝病的患病率为9.78%,其中2.17%社区T2DM患者可能未早期诊断早期干预,已合并肝硬化门静脉高压,应加强该部分患者的管理。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔应助晴云采纳,获得10
刚刚
快乐小狗完成签到 ,获得积分10
刚刚
珞珈完成签到,获得积分10
刚刚
Ya完成签到,获得积分10
刚刚
谦让文昊完成签到,获得积分10
1秒前
小红勇闯科研界完成签到,获得积分10
3秒前
科研通AI2S应助长安采纳,获得10
5秒前
5秒前
6秒前
Amber完成签到,获得积分10
6秒前
6秒前
teborlee完成签到,获得积分10
7秒前
xinxin完成签到,获得积分10
7秒前
SYLH应助鳗鱼鸽子采纳,获得10
7秒前
YY完成签到,获得积分10
8秒前
老德完成签到,获得积分10
8秒前
靓丽的熠彤完成签到,获得积分10
9秒前
深情海秋完成签到,获得积分10
9秒前
10秒前
歇洛克完成签到,获得积分10
11秒前
cao完成签到,获得积分20
11秒前
为你博弈完成签到,获得积分10
12秒前
12秒前
于情信芳完成签到,获得积分10
12秒前
庚小马发布了新的文献求助10
12秒前
淡然妙竹发布了新的文献求助10
13秒前
炒栗子发布了新的文献求助10
13秒前
晴云发布了新的文献求助10
13秒前
14秒前
PHW完成签到,获得积分10
14秒前
monly应助Fin2046采纳,获得30
15秒前
Hello应助JJG采纳,获得10
15秒前
李健的小迷弟应助WJH采纳,获得10
15秒前
17秒前
ty发布了新的文献求助10
17秒前
刘逸藩完成签到,获得积分10
17秒前
yulian完成签到,获得积分10
18秒前
chemhub完成签到,获得积分10
18秒前
歇洛克发布了新的文献求助10
18秒前
Lee发布了新的文献求助10
18秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048